Idiopathic priapism

R D Pitetti1, A Nangia, M S Bhende

  • 1Department of Pediatrics, Children's Hospital of Pittsburgh, Pennsylvania, USA. pitettr@chplink.chp.edu

Pediatric Emergency Care
|December 23, 1999
PubMed

Insights

Idiopathic priapism is uncommon in pediatric patients. This study presents two cases, discusses priapism in children, and offers a diagnostic and management algorithm.

Area of Science:

  • Pediatric Urology
  • Adolescent Medicine
  • Emergency Medicine

Background:

  • Priapism, a prolonged erection, is a rare urological emergency in children.
  • Idiopathic priapism, with no identifiable underlying cause, is even less common.
  • Prompt diagnosis and management are crucial to prevent penile damage.

Observation:

  • Two pediatric cases of idiopathic priapism were observed.
  • Detailed clinical information and diagnostic approaches for these cases were reviewed.
  • The presentation highlights the rarity and diagnostic challenges of this condition in children.

Findings:

  • The study emphasizes the infrequent occurrence of idiopathic priapism in the pediatric population.
  • A comprehensive review of priapism, with a specific focus on idiopathic cases, is provided.
  • An effective algorithm for the diagnosis and management of pediatric priapism is proposed.

Implications:

  • The presented algorithm can guide clinicians in the timely and appropriate care of children with priapism.
  • Increased awareness of idiopathic priapism in children may improve diagnostic accuracy.
  • Effective management strategies are essential to preserve penile function and prevent long-term complications.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...